137 related articles for article (PubMed ID: 11245067)
1. Serum levels of epinephrine and norepinephrine in cirrhotic patients with portal hypertension.
Zhu J; Leng X; Zhao H; Chen L; Du R
Chin Med J (Engl); 1998 Jun; 111(6):504-6. PubMed ID: 11245067
[TBL] [Abstract][Full Text] [Related]
2. [Serum adrenaline and noradrenaline levels in cirrhosis patients with portal hypertension].
Zhu J; Du R; Leng X
Zhonghua Wai Ke Za Zhi; 1996 Mar; 34(3):144-6. PubMed ID: 9387666
[TBL] [Abstract][Full Text] [Related]
3. Plasma catecholamines in patients with presinusoidal portal hypertension: comparison with cirrhotic patients and nonportal hypertensive subjects.
Gaudin C; Braillon A; Poo JL; Kleber G; Moreau R; Lebrec D
Hepatology; 1991 May; 13(5):913-6. PubMed ID: 2029995
[TBL] [Abstract][Full Text] [Related]
4. [Plasma prostacyclin (PGI2) levels in peripheral venous, arterial and portal venous blood in cirrhotic patients with portal hypertension and their clinical implication].
Yin J; Leng X; Zhu J
Zhonghua Wai Ke Za Zhi; 1995 Sep; 33(9):563-5. PubMed ID: 8731881
[TBL] [Abstract][Full Text] [Related]
5. Effect of oral propranolol administration on azygos, renal and hepatic uptake and output of catecholamines in cirrhosis.
Bendtsen F; Christensen NJ; Sørensen TI; Henriksen JH
Hepatology; 1991 Aug; 14(2):237-43. PubMed ID: 1860681
[TBL] [Abstract][Full Text] [Related]
6. [Plasma level of glucagon in cirrhotic patients with portal hypertension during operation of portacaval shunts].
Feng H; Zhang Z; Leng X; Li S; Zhu J; Du R
Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):222-4. PubMed ID: 11829825
[TBL] [Abstract][Full Text] [Related]
7. Plasma norepinephrine and epinephrine levels in essential hypertension.
Goldstein DS; Lake CR
Fed Proc; 1984 Jan; 43(1):57-61. PubMed ID: 6690339
[TBL] [Abstract][Full Text] [Related]
8. Alpha-1 adrenergic receptors in liver plasma membranes of cirrhotic patients with portal hypertension: a quantitative study.
Zhang Y; Leng X; Zhu J; Peng J; Du R
Chin Med J (Engl); 1998 Jun; 111(6):507-9. PubMed ID: 11245068
[TBL] [Abstract][Full Text] [Related]
9. Portal levels of the isoprostane F2 alpha-III, a marker of lipid peroxidation, do not correlate with increased portal pressure in cirrhotic patients.
Praticò D; Rossi E; Merli M; Riggio O; FitzGerald GA; Violi F
J Investig Med; 1998 Dec; 46(9):430-4. PubMed ID: 9861778
[TBL] [Abstract][Full Text] [Related]
10. [The role of nitric oxide in the pathogenesis of portal hypertension].
Zhu J; Wang D; Leng X; Zhang Z; Wang F; Peng J; Du R
Zhonghua Wai Ke Za Zhi; 2000 Feb; 38(2):95-7. PubMed ID: 11831997
[TBL] [Abstract][Full Text] [Related]
11. Urotensin II: a novel vasoactive mediator linked to chronic liver disease and portal hypertension.
Kemp W; Krum H; Colman J; Bailey M; Yandle T; Richards M; Roberts S
Liver Int; 2007 Nov; 27(9):1232-9. PubMed ID: 17919235
[TBL] [Abstract][Full Text] [Related]
12. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
[TBL] [Abstract][Full Text] [Related]
13. Factors participating in the development and mortality of variceal bleeding in portal hypertension--possible effects of the kidney damage and malnutrition.
Lata J; Husová L; Juránková J; Senkyrík M; Díte P; Dastych M; Dastych M; Kroupa R
Hepatogastroenterology; 2006; 53(69):420-5. PubMed ID: 16795985
[TBL] [Abstract][Full Text] [Related]
14. Portal hemodynamics in cirrhotics with portal hypertension using color Doppler velocity profile.
Huang J; Yin X; Lu M; Chen J; Liang L
Chin Med J (Engl); 1999 Jul; 112(7):627-31. PubMed ID: 11601258
[TBL] [Abstract][Full Text] [Related]
15. Portal vein hemodynamics in cirrhotic patients with portal hypertensive gastropathy: an echo-Doppler study.
Iwao T; Toyonaga A; Ikegami M; Sumino M; Oho K; Shigemori H; Sakaki M; Nakayama M; Tanikawa K; Iwao J
Hepatogastroenterology; 1994 Jun; 41(3):230-4. PubMed ID: 7959544
[TBL] [Abstract][Full Text] [Related]
16. [Expression of local angiotensinogen mRNA and activation of local nuclear factor-kappaB in vasculopathy of portal hypertension].
Sun Z; Yang Z; Xu JY
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(32):2283-6. PubMed ID: 16321211
[TBL] [Abstract][Full Text] [Related]
17. Correlations of portal hypertensive gastropathy of hepatitis B cirrhosis with other factors.
Pan WD; Xun RY; Chen YM
Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):527-31. PubMed ID: 14607680
[TBL] [Abstract][Full Text] [Related]
18. Effects of nitric oxide inhibitor on prostacyclin biosynthesis in portal hypertensive rats.
Cao H; Wu Z; Zhou J; Chen Z; Kuang Y
Chin Med J (Engl); 1999 Jun; 112(6):516-9. PubMed ID: 11601330
[TBL] [Abstract][Full Text] [Related]
19. MR findings of the brain in children and adolescents with portal hypertension and the relationship with blood manganese levels.
Pinto RB; Fröehlich PE; Pitrez EH; Bragatti JA; Becker J; Cornely AF; Schneider AC; da Silveira TR
Neuropediatrics; 2010 Feb; 41(1):12-7. PubMed ID: 20571985
[TBL] [Abstract][Full Text] [Related]
20. Changes in serum ammonia concentration in cirrhotic patients with Helicobacter pylori infection.
Si J; Cao Q; Gao M; Fang L; Qian G; Wang Y
Chin Med J (Engl); 2000 Dec; 113(12):1080-1. PubMed ID: 11776140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
